Head‐to‐head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing | ||
| dc.conicet.organizacion | Pontificia Universidad Javeriana | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.conicet.organizacion | Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas | |
| dc.conicet.organizacion | Dirección Nacional de Instituto de Investigación.Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | Universidad Nacional de Colombia | |
| dc.conicet.organizacion | Universite de Nantes | |
| dc.conicet.organizacion | Pontificia Universidad Javeriana | |
| dc.conicet.organizacion | Universidad Popular del Cesar | |
| dc.contributor.author | Ceballos Garzon, Andrés | |
| dc.contributor.author | Garcia, Guillermo Manuel | |
| dc.contributor.author | Cordoba, Susana | |
| dc.contributor.author | Rodriguez, Jose Y. | |
| dc.contributor.author | Alvarez Moreno, Carlos | |
| dc.contributor.author | Pape, Patrice Le | |
| dc.contributor.author | Parra Giraldo, Claudia Marcela | |
| dc.contributor.author | Morales López, Soraya | |
| dc.date.issued | 2022-04 | |
| dc.description.abstract | The susceptibility of 31 Candida auris clinical isolates was evaluated by four methods, namely the microdilution reference method according to Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines as well as Etest and VITEK®2. Essential agreement between the two reference methods was 90%. Etest showed a better overall agreement with the reference methods (94% and 81% for CLSI and EUCAST, respectively) than VITEK®2 (70% and 72%, respectively). Discrepancies were found for fluconazole (FLC) and amphotericin B. Considering categorical agreement (CDC tentative breakpoints), the majority of isolates were considered FLC-resistant (93.6% and 80.6% by CLSI and EUCAST, respectively). Furthermore, all isolates were considered susceptible to echinocandins by all methods. Susceptibility results should be interpreted with care if the VITEK®2 system is used to guide therapeutic decisions for C. auris infections. | es |
| dc.description.fil | Fil: Ceballos Garzon, Andrés. Pontificia Universidad Javeriana; Colombia | |
| dc.description.fil | Fil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas; Argentina | |
| dc.description.fil | Fil: Cordoba, Susana. Dirección Nacional de Instituto de Investigación.Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"; Argentina | |
| dc.description.fil | Fil: Rodriguez, Jose Y.. No especifíca; | |
| dc.description.fil | Fil: Alvarez Moreno, Carlos. Universidad Nacional de Colombia; Colombia | |
| dc.description.fil | Fil: Pape, Patrice Le. Universite de Nantes; Francia | |
| dc.description.fil | Fil: Parra Giraldo, Claudia Marcela. Pontificia Universidad Javeriana; Colombia | |
| dc.description.fil | Fil: Morales López, Soraya. Universidad Popular del Cesar; Colombia | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Ceballos Garzon, Andrés; Garcia, Guillermo Manuel; Cordoba, Susana; Rodriguez, Jose Y.; Alvarez Moreno, Carlos; et al.; Head‐to‐head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing; Elsevier Science; International Journal of Antimicrobial Agents; 59; 4; 4-2022; 1-5 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0924-8579 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/299690 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 1-5 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | International Journal of Antimicrobial Agents | es |
| dc.journal.volume | 59 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier Science | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S0924857922000528 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.ijantimicag.2022.106558 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | CANDIDA AURIS | es |
| dc.subject | CLSI | es |
| dc.subject | ETEST | es |
| dc.subject | EUCAST | es |
| dc.subject | SUSCEPTIBILITY TESTING | es |
| dc.subject.classification | Micología | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Head‐to‐head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b70b204d-750f-4f1e-a96c-2e14d773683d_E.pdf
- Tamaño:
- 989.22 KB
- Formato:
- Adobe Portable Document Format